Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
22 April 2011

IN THIS ISSUE
GSK divestitures
EMA update
US patents
African drug quality

 
GSK considers OTC divestitures
GlaxoSmithKline (GSK) identified certain over-the-counter (OTC) brands in its consumer healthcare business that the company plans to divest. GSK had announced in February 2011 its intention to divest noncore OTC products as part of a strategy in its consumer healthcare business to focus on fast-growing priority brands and emerging markets. More...
 
EMA concludes class review of bisphosphonates
The EMA has concluded a class review of bisphosphonates, adopted a number of positive opinions for new medicines and revealed more about the ongoing studies regarding GlaxoSmithKline’s Pandemrix pandemic influenza vaccine and a possible link with narcolepsy. More...
 
Congress to overhaul US patent laws
US patent laws are undergoing their first large revision since the Patent Act of 1952, with the America Invents Act, introduced by Senator Leahy in January. More...
 
USP drug quality pilot underway in sub-Saharan Africa
Scientists from the national laboratories of five African nations gathered in Ghana this week to take part in technical training conducted by the US Pharmacopeia (USP) that will teach them how to detect substandard and counterfeit medicines. More...
 
Record number of cancer therapies in development
Nearly 900 therapies for the treatment, diagnosis, or prevention of cancer are currently in development, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA) — more than double the number of therapies that were in development six years ago. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Pharma and the Earth
Big pharma and buyer’s remorse
Enhancing the biosimilars industry
More blog posts

Peer-reviewed research
Delivering tamoxifen within solid lipid nanoparticles
Calculating and understanding particulate contamination risk
Improving solid dosage forms with dry granulation
More articles

Upcoming events
Pharmaceutical Compliance Forum 5th Intl Pharmaceutical Compliance Congress (2–5 May | Turkey)
Respiratory Drug Delivery Europe 2011 (3–6 May | Germany)
ExcipientFest (10–11 May | USA)
More events

Product Profiles
Avantor

Improve the Performance and Lower the Costs of ODT Drug Applications
J.T.Baker® PanExcea™ MC200G performance excipient from Avantor™ Performance Materials (formerly Mallinckrodt Baker) is an orally disintegrating tablet (ODT). Read more...

 
Sepha

Global packaging machinery expert, Sepha Ltd, has developed the world's first tool-less, vision-based leak detection machine for blister-packs.
Read more...


Live Webcast
Evonik

May 3rd 2011, 11:00am – 12:00pm EDT
Strategies in Bioavailability Enhancement of Poorly Permeable Small and Large Molecular Entities (BCS III & IV) Learn the challenges of formulating poorly permeable drugs and the importance for therapeutic applications and understand strategies to enhance bioavailability of such drugs . Read more...


Event Profile
 


10th Annual Biological Production Forum 2011
20-22 June 2011
Sheraton Frankfurt Airport Hotel and Conference Center
Frankfurt, Germany
10th Annual Biological Production Forum 2011 is well established as the event for both upstream and downstream processing for biological manufacturing, production and cGMP specialists. Read more...



Survey
Do you think that quality by design has become or is becoming an important element in the CMC requirements between a contract manufacturing organization and sponsor company?
Yes 84%
 
No 16%

This week we would like to know...

What is driving new developments in immediate-release drug delivery?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.